Stay updated on NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial

Sign up to get notified when there's something new on the NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added new MedlinePlus Genetics topic: Schizophrenia; no deletions.
    Difference
    0.3%
    Check dated 2025-10-12T14:01:45.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Update includes a new operating-status notice and version bump to v3.2.0; a topic on Schizophrenia under MedlinePlus Genetics was removed.
    Difference
    6%
    Check dated 2025-10-05T09:06:02.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Page updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.
    Difference
    0.6%
    Check dated 2025-09-28T03:03:27.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page version was updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.
    Difference
    0.3%
    Check dated 2025-09-13T16:19:48.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The web page has been updated to include information on Schizophrenia under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.
    Difference
    0.6%
    Check dated 2025-09-06T13:54:15.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, specifically replacing 'Saint Louis' with 'St Louis' and removing some related topics while adding new ones about counterfeit and substandard drugs.
    Difference
    2%
    Check dated 2025-08-30T08:35:04.000Z thumbnail image

Stay in the know with updates to NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial page.